Development and Validation of HPLC-UV Method for the Determination of a Potent Synthetic Cannabinoid THJ-2201 in Mouse Plasma and Application in a Pharmacokinetic Study

Author(s): Hassan Y. Aboul-Enein*, Gamal A.E Mostafa*, Haitham AlRabiah, Mohammed Al-Ramadi, Sabry M. Attia, Hebatallah A. Wagdy

Journal Name: Current Pharmaceutical Analysis

Volume 16 , Issue 4 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Aim: A new simple and sensitive high-Performance Liquid Chromatography (HPLC) method for the determination of a potent synthetic cannabinoid THJ-2201, has been developed and validated. Lixiviptan was used as the Internal Standard (IS).

Methods: THJ-2201 and IS were extracted from mouse plasma using deproteinization procedure that uses acetonitrile followed by HPLC analysis. The separation was carried out on a reversed-phase C18 column using water and acetonitrile mixture (30:70 v/v). The flow-rate was 1.0 mL/min. Eluting of both THJ-2201 and lixivaptan was performed at 220 nm.

Results: The method demonstrated linearity over a calibration range of 95 - 1500 ng/mL and the Limit of Detection (LOD) and Quantitation (LOQ) were 28 ng/mL and 91 ng/mL, respectively. The validation of the proposed method was carried out by following the US Food and Drug Administration (FDA) guidelines. Intra- and inter-day precision did not exceed 6.4%, whereas the accuracy of THJ-2201 measurements was within ±13%.

Conclusion: This new method is simple and sensitive and has been applied successfully in a pharmacokinetic study of THJ-2201 in mouse plasma. The mean values of Tmax and Cmax were 0.25 h and 141.87 ± 12.11 ng/mL, respectively.

Keywords: THJ-2201, HPLC, validation, mouse plasma, pharmacokinetic study, synthetic cannabinoid.

Diao, X.; Wohlfarth, A.; Pang, S.; Scheidweiler, K.B.; Huestis, M.A. High resolution mass spectrometry for characterizing the metabolism of synthetic cannabinoid thj-018 and its 5-fluoro analog THJ-2201 after incubation in human hepatocytes. Clin. Chem., 2016, 62(1), 157-169.
[] [PMID: 26430074]
Shevyrin, V.; Melkozerov, V.; Nevero, A.; Eltsov, O.; Morzherin, Y.; Shafran, Y. 3-Naphthoylindazoles and 2-naphthoylbenzoimidazoles as novel chemical groups of synthetic cannabinoids: chemical structure elucidation, analytical characteristics and identification of the first representatives in smoke mixtures. Forensic Sci. Int., 2014, 242, 72-80.
[] [PMID: 25036783]
Uchiyama, N.; Shimokawa, Y.; Kawamura, M.; Kikura-Hanajiri, R.; Hakamatsuka, T. Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol., 2014, 32(2), 266-281.
Karila, L.; Benyamina, A.; Blecha, L.; Cottencin, O.; Billieux, J. The synthetic cannabinoids phenomenon. Curr. Pharm. Des., 2016, 22(42), 6420-6425.
[] [PMID: 27655416]
Hermanns-Clausen, M.; Kneisel, S.; Szabo, B.; Auwärter, V. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction, 2013, 108(3), 534-544.
[] [PMID: 22971158]
Seely, K.A.; Lapoint, J.; Moran, J.H.; Fattore, L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2012, 39(2), 234-243.
[] [PMID: 22561602]
Hess, C.; Stockhausen, S.; Kernbach-Wighton, G.; Madea, B. Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids? Forensic Sci. Int., 2015, 257, e6-e11.
[] [PMID: 26363623]
Koppel, B.S.; Brust, J.C.M.; Fife, T.; Bronstein, J.; Youssof, S.; Gronseth, G.; Gloss, D. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 2014, 82(17), 1556-1563.
[] [PMID: 24778283]
Sarfaraz, S.; Adhami, V.M.; Syed, D.N.; Afaq, F.; Mukhtar, H. Cannabinoids for cancer treatment: progress and promise. Cancer Res., 2008, 68(2), 339-342.
[] [PMID: 18199524]
Wolff, K.; Brimblecombe, R.; Forfar, J.C.; Forrest, A.R.; Gilvarry, E.; Johnston, A.; Morgan, J.; Osselton, M.D.; Read, L.; Taylor, D. Driving under the influence of drugs., 2013.
Fergusson, D.M.; Horwood, L.J.; Boden, J.M. Is driving under the influence of cannabis becoming a greater risk to driver safety than drink driving? Findings from a longitudinal study. Accid. Anal. Prev., 2008, 40(4), 1345-1350.
[] [PMID: 18606265]
Vikingsson, S.; Gréen, H. Putting designer drugs back in pandora’s box: Analytical challenges and metabolite identification. Clin. Chem., 2016, 62(1), 4-5.
[] [PMID: 26546634]
Lang, J.R.; Bolton, S. A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry--1. Experimental considerations. J. Pharm. Biomed. Anal., 1991, 9(5), 357-361.
[] [PMID: 1932270]
González, O.; Blanco, M.E.; Iriarte, G.; Bartolomé, L.; Maguregui, M.I.; Alonso, R.M. Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect. J. Chromatogr. A, 2014, 1353(1), 10-27.
[] [PMID: 24794936]
Waiver of. In vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification. System Guidance for Industry, 2014.
Gatch, M.B.; Forster, M.J.Δ. Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats. Psychopharmacology (Berl.), 2016, 233(10), 1901-1910.
[] [PMID: 26875756]
Pucci, V.; Bugamelli, F.; Mandrioli, R.; Ferranti, A.; Kenndler, E.; Raggi, M.A. High-performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean-up procedures. Biomed. Chromatogr., 2004, 18(1), 37-44.
[] [PMID: 14872547]
Miller, J.N.; Miller, J.C. Statistics and Chemometrics for Analytical Chemistry, Sixth Edition;; Weston, P., Ed.; Limited, Essex CM20 2JE: England,, 2010.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [404 - 411]
Pages: 8
DOI: 10.2174/1573412915666190204144843
Price: $65

Article Metrics

PDF: 26